Fortress Biotech Inc. (NASDAQ:FBIO) shares saw an uptick in trading volume on Wednesday . 91,474 shares traded hands during trading, an increase of 13% from the previous session’s volume of 80,608 shares.The stock last traded at $3.14 and had previously closed at $3.05.

Separately, FBR & Co reiterated an “outperform” rating on shares of Fortress Biotech in a report on Wednesday, July 20th.

The company’s market capitalization is $152.34 million. The stock has a 50-day moving average of $2.79 and a 200 day moving average of $2.96.

Fortress Biotech (NASDAQ:FBIO) last issued its quarterly earnings results on Monday, May 9th. The biopharmaceutical company reported ($0.31) earnings per share (EPS) for the quarter. Analysts predict that Fortress Biotech Inc. will post ($1.23) EPS for the current fiscal year.

Fortress Biotech, Inc, formerly Coronado Biosciences, Inc, is a biopharmaceutical company. The Company is involved in the development of immunotherapy agents for the treatment of autoimmune diseases and cancer. Its sole product candidate is CNDO-109. The Company is also focused on acquiring, developing and commercializing pharmaceutical and biotechnology products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.